CRP and diffuse large B-cell lymphoma: In patients with DLBCL, we found that inflammation, as assessed by CRP and PA, was prognostically predictive for both OS and PFS, especially in the short-term (0–90 days after the DLBCL diagnosis), but also up to one year after diagnosis.